Search
News Archive
Categories
Aker BioMarine Antarctic Announces New COO
Posted On: May 12, 2012Aker BioMarine Antarctic announced the promotion of Matts Johansen to the position of chief operating officer. Johansen has served as executive vice president of marketing and sales since October 2009. During his tenure he has overseen sales growth in North America and Europe, and the development of the Asian markets in parallel with regulatory filings.
In this new role Johansen will be responsible for marketing and sales, business development, regulatory, research and development, shore-based production and process development.
Algae.Tec Commissions Australian Biofuels Facility
Posted On: May 12, 2012Perth, Australia-based Algae.Tec, an advanced algae to biofuels company manufacturing enclosed algae growth and harvesting systems, has announced the commissioning for its showcase biofuels facility, Shoalhaven One, in Nowra, Australia. Algae.Tec Executive Chairman Roger Stroud said the commissioning process was on track for production of algae biomass in early June, ramping up to capacity by the end of June.
Growing International Interest In Oceanology To Benefit The Global Marine Biotechnology Market, According To New Report By Global Industry Analysts, Inc.
Posted On: April 24, 2012With growing environmental pollution throwing the spotlight on sustainable industrial development, there exists huge demand for suitable, scalable, economically, socially and environmentally sustainable feedstock options for the manufacturing industry. With sustainable feedstock production and delivery ballooning into a massive industry worldwide, the world’s oceans have emerged into the next frontier for investigative, biological resource development and management R&D projects.
For instance, marine-derived cosmetic ingredients, marine-derived molecules including enzymes, biopolymers and biomaterials, marine-derived pharmaceuticals, among others, are now becoming the mainstay of most R&D projects worldwide. The marine biotechnology sector is also attracting increased venture capital funds as is mirrored by the mushrooming of potential laden start-up firms focused on developing novel compounds from marine organisms.
As stated by the new market research report on Marine Biotechnology, Bioactive Substances represents one of the fastest growing market sectors trailing a projected CAGR of approximately 4.7% respectively.
The research report titled “Marine Biotechnology: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the marine biotechnology markets, impact of recession on the markets, current market trends, key growth drivers, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants.
Sapphire Energy gets $144M in its fuel tank to turn algae into gasoline
Posted On: April 13, 2012Sapphire Energy, a company that creates algae-based fuel, just announced a whopping $144 million in funding.
In recent years several startups have emerged to create fuel out of plant material, all hoping to lure people away from gasoline made from crude oil. Solazyme, Algae.tec, and Sapphire Energy all dominate the space, trying to edge out not only each other but oil companies as well.
All three companies covert algae into a petroleum replacement, one that can work with the traditional cars we already have on the road.
NUI Galway’s participation in Energetic Algae project (EnAlgae) investigates algae as sustainable energy source
Posted On: March 23, 2012Seaweed is big business in Asia, where it is cultivated and used in a variety of food and beauty products. Nine-tenths of the world’s production for commercial use takes place in China, Japan and Korea. It is also commonly used as a sugar-rich animal feedstock in the US.
Of the 500 species that can be found in Ireland, though, only a small number are harvested. Now researchers in at NUI Galway’s Ryan Institute are taking part in a European collaborative project to investigate the potential of algae as a source of sustainable energy.
Algal bio-energy development is still in its infancy, but NUI Galway’s participation in the Energetic Algae project (EnAlgae), a four-year, €1.2-million initiative which hopes to shed more light on this undervalued resource.
UK’s Novel Food Panel Looks at Shrimp Oil Safety
Posted On: February 23, 2012Oil produced from shrimp could soon be used as an ingredient in food supplement products in Europe.
But since the oil is a new and novel food ingredient with no significant history of consumption in the European Union before May 15, 1997, the product, to be known by the trade name Calanus® Oil, must go through the United Kingdom’s Advisory Committee on Novel Foods and Processes (ACNFP).
An arm of the Food Standards Agency, the ACNFP is taking public comments on the Calanus® oil application until March 1, 2012Comments are considered by the committee during its assessment of the novel food ingredient.
Calanus AS of Norway is the applicant. It plans to market the oil taken from the miniature shrimp Calanus finmarchicus, one of the most common zooplankton found in the North Atlantic Ocean.
Fish Oil Fortification of Soft Goat Cheese
Posted On: February 22, 2012A new study in the February issue of the Journal of Food Science, published by the Institute of Food Technologists, shows that fish oil can be added to goat cheese to deliver high levels of heart-healthy omega-3 fatty acids without compromising taste or shelf-life.
Fish oil is an underused ingredient in the food industry because of its association with a strong odor and aftertaste. A new study in the February issue of the Journal of Food Science, published by the Institute of Food Technologists, shows that fish oil can be added to goat cheese to deliver high levels of heart-healthy omega-3 fatty acids without compromising taste or shelf-life.
New study shows that humans can absorb similar omega-3 levels from fish oil capsules or fruit juice as they can from eating salmon paté
Posted On: February 22, 2012A new study shows that humans can absorb just as much omega-3 from fish oil capsules or fruit juice as they can from eating salmon paté.
“We can see that just as much omega-3 is absorbed into the bloodstream regardless of whether we take in these long-chain marine fatty acids in capsules, enriched fruit juice or enriched fish paté,” explains Senior Research Scientist Bente Kirkhus of Nofima.
In the study, 159 healthy men and women were randomly divided into four groups. One group ate 34 grams of salmon paté, another drank 500ml of enriched fruit juice and a third took three capsules of concentrated fish oil. Over a seven week period, they all had a daily intake of 1 gram of omega-3, which includes the important long-chain fatty acids EPA and DHA. The fourth group was a control group and received no omega-3 supplements.
United States Patent and Trademark Office issues patent to Heliae
Posted On: January 12, 2012Heliae, an Arizona-based algae technology company, announced today three significant additions to its expanding portfolio of intellectual property.
The United States Patent and Trademark Office issued patent number 8,084,038 to Heliae entitled “Methods of and Systems for Isolating Nutraceutical Products from Algae” on December 27, 2011. Heliae has received a Notice of Allowance from the USPTO for two additional patent applications focused on Heliae’s breakthrough extraction technology. These patents are expected to issue in the first half of February.
NZ Biotech company Photonz successfully transfers omega-3 fermentation process to industrial scale Canadian pilot plant
Posted On: November 27, 2011Biotech company Photonz Corporation has achieved a major milestone on the path to commercially manufacturing, by fermentation, the high-value omega-3 fatty acid, eicosapentaenoic acid (EPA). It has successfully transferred its strain and fermentation process, developed in Auckland, to a contract facility in Canada, which has then used that process to ferment material from algal biomass in a 7.5 tonne industrial scale reactor. This demonstrates the feasibility of commercial production of EPA from marine microalgae.
The Canadian facility has a battery of reactors and support utilities that enable it to operate multi-tonne scale fermentations under industrial conditions. During the project it produced sufficient biomass for Photonz to complete development of the downstream purification processes for its EPA product, also at pilot industrial scale.
Host
 |
Partners
  |
Sponsors
 |
 |
Share Aquapreneur
